Our proven track record in liaising with the European Medicines Agency (EMA), as well as National Competent Authorities (NCA), enables us to identify valuable information and regulatory trends from which our clients will benefit.
The changing perception of regulators with regard to Drug and Medical Devices development matters can be extremely critical when creating optimal regulatory strategies for the successful development of a specific product.
DDR will translate its knowledge on regional and global regulatory requirements into strategies that will help you to navigate through the changing regulatory environment that governs the development of Drugs and Medical Devices.
How can DDR help?
- DDR offers a complete regulatory accompaniment supporting the consortium activities during the whole project’s development, thanks to our gained experience and several successes in multi-national collaboration proposals granted by the EC.
- DDR will contribute to the preparation of proposals from early stages.